Copyright
©2012 Baishideng.
World J Transplant. Aug 24, 2012; 2(4): 51-68
Published online Aug 24, 2012. doi: 10.5500/wjt.v2.i4.51
Published online Aug 24, 2012. doi: 10.5500/wjt.v2.i4.51
Classification | Drug (Generic) | Drug (Trade) | Generic | Dosage form |
Interleukin-2 receptor blockers | Basiliximab | Simulect® | No | Injection |
Anti-T cell therapy | Antithymocyte globulin - horse | Atgam® | No | Injection |
Antithymocyte globulin - rabbit | Thymoglobulin® | No | Injection | |
Corticosteroids | Methylprednisolone | Solumedrol® | Yes | Injection, oral |
Prednisone | Deltasone® | Yes | Oral | |
Calcineurin inhibitors | Cyclosporine, CsA | Sandimmune® | Yes | Injection, oral |
Cyclosporine microemulsion | Neoral® | Yes | Injection, oral | |
Tacrolimus, FK506 | Prograf® | Yes | Oral | |
mTOR inhibitors | Sirolimus, rapamycin | Rapamune® | No | Oral |
Everolimus | Zortress® | No | Oral | |
Anti-proliferative | Azathioprine, AZA | Imuran® | Yes | Injection, oral |
Mycophenolate mofetil, MMF | Cellcept® | Yes | Injection, oral | |
Mycophenolate sodium,EC-MPS | Myfortic® | No | Oral | |
Costimulation blockade | Belatacept | Nulojix® | No | Injection |
- Citation: Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012; 2(4): 51-68
- URL: https://www.wjgnet.com/2220-3230/full/v2/i4/51.htm
- DOI: https://dx.doi.org/10.5500/wjt.v2.i4.51